Panagiotis Tsourapas compensation by year
COLGATE PALMOLIVE Summary Compensation Table · all 4 fiscal years held| Component | FY2020 | FY2021 | FY2024 | FY2025 |
|---|---|---|---|---|
| Salary | $751,617 | $800,475 | $947,215 | $1,001,812 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $904,184 | $1,356,976 | $1,384,831 | $1,312,348 |
| Option awards | $787,502 | $831,250 | $579,002 | $600,001 |
| Non-equity incentive | $1,075,620 | $683,783 | $1,332,872 | $871,760 |
| Pension and deferred compensation | $2,384 | $1,964 | $4,702 | $4,843 |
| All other | $126,516 | $188,508 | $231,069 | $288,797 |
| Total | $3,647,823 | $3,862,956 | $4,479,691 | $4,079,561 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: COLGATE PALMOLIVE CO DEF 14A filed March 25, 2026, accession 0001308179-26-000136, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 43,222 | $3,415,402 | — |
| RSU | 34,660 | $2,738,833 | — |
| Option | 17,042 | — | $106.34 |
| Option | 12,962 | — | $72.83 |
| Option | 32,949 | — | $84.06 |
Per the Outstanding Equity Awards at Fiscal Year-End table in COLGATE PALMOLIVE CO's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
6 Form 4 lines since the FY2025 proxy (filed March 25, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-16 | Grant or award | — | 4,597 | $0.00 | 11,447 |
| 2026-09-16 | Grant or award derivative | — | 31,814 | $0.00 | 31,814 |
| 2026-09-13 | Tax withholding | — | 922 | $86.80 | 6,850 |
| 2026-09-12 | Tax withholding | — | 618 | $86.80 | 7,772 |
| 2026-09-11 | Tax withholding | — | 684 | $86.80 | 8,390 |
| 2026-08-24 | Sale | — | 10,000 | $92.05 | 64,901 |
The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments COLGATE PALMOLIVE discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $1,537,500 | $0 | $0 | $2,409,260 |
| Disability | $0 | $80,235 | $0 | $951,995 |
| Change in control and involuntary termination | $4,454,219 | $5,298,241 | $616,147 | $11,240,367 |
| Death | $0 | $80,235 | $0 | $951,995 |
| Retirement | $0 | $0 | $0 | $871,760 |
Per the Potential Payments Upon Termination or Change in Control table in COLGATE PALMOLIVE CO's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
COLGATE PALMOLIVE’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Noel Wallace | Chairman, President and Chief Executive Officer | $16,478,196 |
| Shane Grant | Chief Operating Officer, Americas | $11,924,112 |
| Stanley Sutula III | Chief Financial Officer | $5,664,299 |
| Panagiotis Tsourapas · this page | Chief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev. | $4,079,561 |
| Jennifer Daniels | Chief Legal Officer and Secretary | $3,770,777 |
The full COLGATE PALMOLIVE compensation record
free company briefThis page is one person within COLGATE PALMOLIVE's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order COLGATE PALMOLIVE's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are COLGATE PALMOLIVE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat